Cargando…

ASCT2/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer

Alanine, serine, cysteine-preferring transporter 2 (ASCT2; SLC1A5) mediates uptake of glutamine, a conditionally essential amino acid in rapidly proliferating tumour cells. Uptake of glutamine and subsequent glutaminolysis is critical for activation of the mTORC1 nutrient-sensing pathway, which regu...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Geldermalsen, M, Wang, Q, Nagarajah, R, Marshall, A D, Thoeng, A, Gao, D, Ritchie, W, Feng, Y, Bailey, C G, Deng, N, Harvey, K, Beith, J M, Selinger, C I, O'Toole, S A, Rasko, J E J, Holst, J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4914826/ https://www.ncbi.nlm.nih.gov/pubmed/26455325 http://dx.doi.org/10.1038/onc.2015.381

Ejemplares similares

ASCT2 regulates glutamine uptake and cell growth in endometrial carcinoma
por: Marshall, A D, et al.
Publicado: (2017)

Targeting ASCT2‐mediated glutamine uptake blocks prostate cancer growth and tumour development
por: Wang, Qian, et al.
Publicado: (2015)

Inhibition of glutamine uptake regulates mTORC1, glutamine metabolism and cell growth in prostate cancer
por: Wang, Qian, et al.
Publicado: (2014)

Homology Modeling Informs Ligand Discovery for the Glutamine Transporter ASCT2
por: Garibsingh, Rachel-Ann A., et al.
Publicado: (2018)

Structural characterisation reveals insights into substrate recognition by the glutamine transporter ASCT2/SLC1A5
por: Scopelliti, Amanda J, et al.
Publicado: (2018)

Intron retention is regulated by altered MeCP2-mediated splicing factor recruitment
por: Wong, Justin J. -L., et al.
Publicado: (2017)

Cryo-EM structures of the human glutamine transporter SLC1A5 (ASCT2) in the outward-facing conformation
por: Yu, Xiaodi, et al.
Publicado: (2019)

Glutamine addiction promotes glucose oxidation in triple-negative breast cancer
por: Quek, Lake-Ee, et al.
Publicado: (2022)

ASCT2 (SLC1A5)-dependent glutamine uptake is involved in the progression of head and neck squamous cell carcinoma
por: Zhang, Ze, et al.
Publicado: (2019)

Targeting of glutamine transporter ASCT2 and glutamine synthetase suppresses gastric cancer cell growth
por: Ye, Jianxin, et al.
Publicado: (2018)

The glutamine transporter ASCT2 (SLC1A5) promotes tumor growth independently of the amino acid transporter LAT1 (SLC7A5)
por: Cormerais, Yann, et al.
Publicado: (2018)

Epigenetic silencing of microRNA-137 enhances ASCT2 expression and tumor glutamine metabolism
por: Dong, J, et al.
Publicado: (2017)

ASCT2 overexpression is associated with poor survival of OSCC patients and ASCT2 knockdown inhibited growth of glutamine‐addicted OSCC cells
por: Luo, Yijun, et al.
Publicado: (2020)

Pharmacological Blockade of ASCT2-dependent Glutamine Transport Leads To Anti-tumor Efficacy in Preclinical Models
por: Schulte, Michael L., et al.
Publicado: (2018)

Ligand Discovery for the Alanine-Serine-Cysteine Transporter (ASCT2, SLC1A5) from Homology Modeling and Virtual Screening
por: Colas, Claire, et al.
Publicado: (2015)

Targeting ASCT2-mediated glutamine metabolism inhibits proliferation and promotes apoptosis of pancreatic cancer cells
por: Wang, Wenbin, et al.
Publicado: (2022)

D-Serine Is a Substrate for Neutral Amino Acid Transporters ASCT1/SLC1A4 and ASCT2/SLC1A5, and Is Transported by Both Subtypes in Rat Hippocampal Astrocyte Cultures
por: Foster, Alan C., et al.
Publicado: (2016)

Cys Site-Directed Mutagenesis of the Human SLC1A5 (ASCT2) Transporter: Structure/Function Relationships and Crucial Role of Cys467 for Redox Sensing and Glutamine Transport
por: Scalise, Mariafrancesca, et al.
Publicado: (2018)

Clinical Role of ASCT2 (SLC1A5) in KRAS-Mutated Colorectal Cancer
por: Toda, Kosuke, et al.
Publicado: (2017)

NDRG2 ablation reprograms metastatic cancer cells towards glutamine dependence via the induction of ASCT2
por: Ding, Mingchao, et al.
Publicado: (2020)

Stage-Specific L-Proline Uptake by Amino Acid Transporter Slc6a19/B(0)AT1 Is Required for Optimal Preimplantation Embryo Development in Mice
por: Treleaven, Tamara, et al.
Publicado: (2022)

Interaction of Cholesterol With the Human SLC1A5 (ASCT2): Insights Into Structure/Function Relationships
por: Scalise, Mariafrancesca, et al.
Publicado: (2019)

Functional and Kinetic Comparison of Alanine Cysteine Serine Transporters ASCT1 and ASCT2
por: Wang, Jiali, et al.
Publicado: (2022)

The Human SLC1A5 (ASCT2) Amino Acid Transporter: From Function to Structure and Role in Cell Biology
por: Scalise, Mariafrancesca, et al.
Publicado: (2018)

Inhibition of glucose metabolism prevents glycosylation of the glutamine transporter ASCT2 and promotes compensatory LAT1 upregulation in leukemia cells
por: Polet, Florence, et al.
Publicado: (2016)

Ag120-Mediated Inhibition of ASCT2-Dependent Glutamine Transport has an Anti-Tumor Effect on Colorectal Cancer Cells
por: Yu, Wei, et al.
Publicado: (2022)

A Novel ASCT2 Inhibitor, C118P, Blocks Glutamine Transport and Exhibits Antitumour Efficacy in Breast Cancer
por: Lyu, Xiao-Dan, et al.
Publicado: (2023)

The basal bodies of Chlamydomonas reinhardtii
por: Dutcher, Susan K., et al.
Publicado: (2016)

Autologous stem cell transplant (ASCT) for AIDS-related lymphoma (ARL)
por: Krishnan, A, et al.
Publicado: (2009)

Increased expression of glutamine transporter SNAT2/SLC38A2 promotes glutamine dependence and oxidative stress resistance, and is associated with worse prognosis in triple-negative breast cancer
por: Morotti, Matteo, et al.
Publicado: (2020)

Low temperature bacterial expression of the neutral amino acid transporters SLC1A5 (ASCT2), and SLC6A19 (B0AT1)
por: Galluccio, Michele, et al.
Publicado: (2020)

ASCT2 (SLC1A5)-Deficient Mice Have Normal B-Cell Development, Proliferation, and Antibody Production
por: Masle-Farquhar, Etienne, et al.
Publicado: (2017)

SP142 PD-L1 Scoring Shows High Interobserver and Intraobserver Agreement in Triple-negative Breast Carcinoma But Overall Low Percentage Agreement With Other PD-L1 Clones SP263 and 22C3
por: Pang, Jia-Min B., et al.
Publicado: (2021)

A Role for p53 in the Adaptation to Glutamine Starvation through the Expression of SLC1A3
por: Tajan, Mylène, et al.
Publicado: (2018)

Targeting glutamine metabolic reprogramming of SLC7A5 enhances the efficacy of anti-PD-1 in triple-negative breast cancer
por: Huang, Renhong, et al.
Publicado: (2023)

Basal bodies bend in response to ciliary forces
por: Junker, Anthony D., et al.
Publicado: (2022)

The Treatment of Multiple Myeloma Patients Not Eligible for Asct
por: Richardson, Paul, et al.
Publicado: (2010)

Rational design of ASCT2 inhibitors using an integrated experimental-computational approach
por: Garibsingh, Rachel-Ann A., et al.
Publicado: (2021)

ASCT2 is the primary serine transporter in cancer cells
por: Conger, Kelly O., et al.
Publicado: (2023)

Delta-Tocotrienol Modulates Glutamine Dependence by Inhibiting ASCT2 and LAT1 Transporters in Non-Small Cell Lung Cancer (NSCLC) Cells: A Metabolomic Approach
por: Rajasinghe, Lichchavi Dhananjaya, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_f04l7sed6q2n5mrv4rtngpan1p